A1 adenosine receptor antagonist (Julius Maximilians-Universitat Wurzburg)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA1 adenosine receptor antagonist (Julius Maximilians-Universitat Wurzburg)
Drug Alias NameA3 adenosine receptor antagonists (Julius-Maximilans-Universitat Wurzburg)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonistsAdenosine A1 receptor antagonists
TargetsAdenosine A3 receptorAdenosine A1 receptor
Therapy Area/IndicationsCognition DisordersArrhythmias, CardiacRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wurzburg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Wurzburg
Active IndicationsN/A
Inactive IndicationsCognition DisordersArrhythmias, CardiacRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A